A play for all non-biologists
Whether it’s dachshunds, giraffes, papaya or humans, all forms of life – with a few exceptions – have the same genetic code. That’s why it’s possible to exchange their genetic material, which results in new characteristics. Biology and engineering provide the basis for synthetic biology. This branch of science not only deals with the exchange of genetic material, but also creates entirely new forms of life. For what purposes are these new creatures needed and who do they belong to? How will they affect our ecosystem? How far can and should research go in altering and creating forms of life? And what does “life” actually mean in times of technological manipulation? The play “EinzigArtig” explores these questions and more, while also showing which seemingly futuristic experiments are already a present reality.
The play is suitable for young people aged 14 and over. General admission is €10, with a reduced rate of €5, and is on a donation basis.
For tickets and further information about the play, check out the website or send an email to einzigartig-theater@gmx.de.
“EinzigArtig” is a production of the JugendTheaterWerkstatt Spandau (jtw spandau) in cooperation with the Wissenschaft im Dialog initiative and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC). The project is funded by the Berlin Senate Department for Culture and Europe.
Dates
- Premiere on Sunday, 17. September 2017 at 8 pm at the Museum für Naturkunde, Berlin
- Monday, 18. September 2017 at 11 am at the Museum für Naturkunde, Berlin (for schools)
- Monday, 18. September 2017 at 7 pm at the Museum für Naturkunde, Berlin
- Friday, 22. September 2017 at 11 am at the jtw Spandau (for schools)
- Saturday, 23. September 2017 at 7 pm at the jtw Spandau
- Tuesday, 26. September 2017 at 4 pm at the Max Delbrück Center, Berlin-Buch (for schools)
- Friday, 6. October 2017 at 4 pm at the Max Delbrück Center, Berlin-Buch
The Max Delbrück Center for Molecular Medicine (MDC)
The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) is one of the world’s leading biomedical research institutions. Max Delbrück, a Berlin native, was a Nobel laureate and one of the founders of molecular biology. At the MDC’s locations in Berlin-Buch and Mitte, researchers from some 60 countries analyze the human system – investigating the biological foundations of life from its most elementary building blocks to systems-wide mechanisms. By understanding what regulates or disrupts the dynamic equilibrium in a cell, an organ, or the entire body, we can prevent diseases, diagnose them earlier, and stop their progression with tailored therapies. Patients should benefit as soon as possible from basic research discoveries. The MDC therefore supports spin-off creation and participates in collaborative networks. It works in close partnership with Charité – Universitätsmedizin Berlin in the jointly run Experimental and Clinical Research Center (ECRC), the Berlin Institute of Health (BIH) at Charité, and the German Center for Cardiovascular Research (DZHK). Founded in 1992, the MDC today employs 1,600 people and is funded 90 percent by the German federal government and 10 percent by the State of Berlin.
